Advanced Intellectual Property Strategies for Defending Your Life Sciences IPO
The Deal's 2nd half M&A scene: Interview with Spencer Klein, Morrison Foerster
Innovative Exit Strategies for Life Sciences Companies – Interview with Bill Whelan, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
Polsinelli Podcast - Emerging Technology & Startup Companies
Digital Health: Where is the Action for Entrepreneurs?
Pepper Hamilton Health Care-Life Sciences Webinar -
The explosion of mobile technology and Web applications linking patients with doctors, pharmacies and medical devices is undergoing scrutiny by the FDA, FTC, HHS and...more
The regulatory enforcement environment in China remains tense, as both the Chinese government and media bring new actions and allegations against life sciences manufacturers in both the pharmaceutical and device sectors. We...more
IN THIS ISSUE:
- A new wave of regulatory enforcement actions in China – Are we witnessing a prolonged enforcement cycle?
- Update on recent decisions
- Australia’s innovation patent – The...more
Many Canadian businesses are involved in researching and developing cutting-edge technology in a number of areas including: information technology, high-tech, life sciences, pharmaceuticals, clean technology, environmental...more
Back to Top